Answers are grounded in this paper and cite their sources.
An optical syringe for targeted delivery of a substrate in vivo has been developed on the basis of the 3,5-dibromo-2,4-dihydroxycinnamic caging group. Two-photon excitation of the caged compound uncages the substrate (ethanol in the scheme) and forms a coumarin whose fluorescence allows the concentration of released substrate to be quantified. Single-cell release can be achieved with a focused laser (shown schematically for a zebrafish embryo).
No takes yet. Share an insight, caveat, or question.
Gagey‐Eilstein et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: